Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.9 USD | +4.50% | -3.97% | -20.94% |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.36 times its sales.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Employment Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.94% | 595M | B+ | ||
-11.18% | 9.72B | A- | ||
-10.77% | 8.16B | A- | ||
-7.35% | 3.52B | A- | ||
-12.72% | 3.09B | C+ | ||
+6.78% | 1.56B | - | ||
-1.25% | 1.49B | - | ||
+14.08% | 1.48B | - | ||
+1.30% | 1.28B | B- | ||
+4.40% | 1.01B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Cross Country Healthcare, Inc. - Nasdaq
- Ratings Cross Country Healthcare, Inc.